CTRI/2020/08/026985尚未招募2 期
Assessment of safety and efficacy of KabasuraKudineer as an add-on therapy in mild to moderate COVID-19. - Nil
Chettinad Hospital and Research Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a.COVID-19 positive patients with mild to moderate disease.
- •b.Males and females aged between 18 and 60 years who are admitted in Chettinad Hospital and Research Institute
- •c.Patients willing to give written informed consent.
排除标准
- •a.Patients Suffering from Chronic diseases- hepatic, renal, Hypertension and Diabetes mellitus
- •b.Pregnancy & lactation
- •c. Severe COVID-19
研究者
相似试验
已完成
2 期
Clinical evaluation of the effect of classical siddha drug karappÄ?ṉ kuá¹inÄ«r cÅ«raá¹?am(internal) and koá¹ivÄ?li eá¹?á¹?ey(external) in the management of skin itchingCTRI/2019/07/019965I BIBINA40
尚未招募
1 期
Clinical study on treatment of female rheumatoid arthritis by Kunbixiao decoctioITMCTR2100004992Xiyuan Hospital, China Academy of Chinese Medical Sciences
尚未招募
2 期
CLINICAL EVALUATION OF KABA SURA KUDINEER IN THE TREATMENT OF KABASURAM (ACUTE BRONCHITIS) IN CHILDRECTRI/2021/08/036067ational Institute of Siddha
尚未招募
2 期
Clinical study on the efficacy and safety of Kunbi Xiao Prescription in the treatment of female rheumatoid arthritisRheumatoid ArthritisITMCTR2200005674Xi Yuan Hospital of China Academy of Chinese Medical Sciences
招募中
2 期
Study of Kusmanda Kshara in Helicobacter Pylori.CTRI/2023/07/055613I